Trial Profile
A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single-dose Auron Misheil therapy in healthy male subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2013
Price :
$35
*
At a glance
- Drugs AMT 2003 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 22 Apr 2013 New trial record